Showing results (11-20 of 569) with videos related to

Sort By:
Pageof 57
The Journal of Biological Chemistry|January 27, 2005
Fanconi anemia complementation group D2 (FANCD2) functions independently of BRCA2- and RAD51-associated homologous recombination in response to DNA damageAkihiro Ohashi, Malgorzata Z Zdzienicka, Junjie Chen, et al.
Breast Cancer Research and Treatment|May 21, 2003
The 17q23 amplicon and breast cancerColleen S Sinclair, Matthew Rowley, Ali Naderi, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 1, 2018
Common Genetic Variation and Breast Cancer Risk-Past, Present, and FutureJenna Lilyquist, Kathryn J Ruddy, Celine M Vachon, et al.
The Journal of Molecular Diagnostics : JMD|March 20, 2012
The germline MLH1 K618A variant and susceptibility to Lynch syndrome-associated tumorsFabiola Medeiros, Noralane M Lindor, Fergus J Couch, et al.
Advances in Experimental Medicine and Biology|March 19, 2016
Genomic Biomarkers for Breast Cancer RiskMichael F Walsh, Katherine L Nathanson, Fergus J Couch, et al.
Cancer Biology & Therapy|November 16, 2006
Altered expression of FANCL confers mitomycin C sensitivity in Calu-6 lung cancer cellsJun Zhang, Xianshu Wang, Chia-Ju Lin, et al.
Familial Cancer|April 6, 2012
Mutation screening of RAD51C in high-risk breast and ovarian cancer familiesWenping Lu, Xianshu Wang, Hongsheng Lin, et al.
British Journal of Cancer|August 30, 2024
BRCA-mutated breast cancer: the unmet need, challenges and therapeutic benefits of genetic testingBanu Arun, Fergus J Couch, Jean Abraham, et al.
Pathology|April 29, 2017
Non-BRCA familial breast cancer: review of reported pathology and molecular findingsMichael G Keeney, Fergus J Couch, Daniel W Visscher, et al.
Pageof 57